Suppr超能文献

[重组促性腺激素(促卵泡生成素、促黄体生成素、人绒毛膜促性腺激素)的临床应用]

[Clinical use of recombinant gonadotropins (FSH, LH, hCG)].

作者信息

Antoine J M, Loumaye E, Alvarez S, Merviel P, Cornet D, Mandelbaum J, Salat-Baroux J

机构信息

Service de Gynécologie-Obstétrique, Hôpital Tenon, Paris.

出版信息

Contracept Fertil Sex. 1997 Feb;25(2):141-6.

PMID:9116774
Abstract

The production of recombinant gonadotropins is independent of urine collection. They have a high specific activity and a better batch to batch consistency than urinary gonadotropins. In our IVF programme 62 normo-ovulatory patients less than 38 years old, with tubal or idiopathic infertility and normal sperm, were treated by r-FSH and randomized into four groups : with or without LHRH agonist, step-up or step-down stimulation. The overall results were higher in the agonist groups, but did not reveal any significant difference between step-up and step-down stimulation.

摘要

重组促性腺激素的生产不依赖于尿液采集。它们具有高比活性,并且与尿促性腺激素相比,批次间一致性更好。在我们的体外受精计划中,62名年龄小于38岁、患有输卵管性或特发性不孕症且精子正常的排卵正常患者,接受了重组促卵泡素(r-FSH)治疗,并随机分为四组:使用或不使用促黄体生成素释放激素(LHRH)激动剂,递增或递减刺激。激动剂组的总体结果更高,但递增和递减刺激之间未显示出任何显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验